PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 4 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | -100.0% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $1,000 | -75.0% | 10,000 | 0.0% | 0.00% | -80.0% |
| Q2 2016 | $4,000 | 0.0% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $4,000 | 0.0% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $4,000 | -71.4% | 10,000 | -60.0% | 0.01% | -68.8% |
| Q3 2015 | $14,000 | 0.0% | 25,000 | 0.0% | 0.02% | +14.3% |
| Q2 2015 | $14,000 | -30.0% | 25,000 | 0.0% | 0.01% | -30.0% |
| Q1 2015 | $20,000 | 0.0% | 25,000 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $20,000 | -23.1% | 25,000 | 0.0% | 0.02% | -16.7% |
| Q3 2014 | $26,000 | +18.2% | 25,000 | 0.0% | 0.02% | +26.3% |
| Q2 2014 | $22,000 | -64.5% | 25,000 | 0.0% | 0.02% | -63.5% |
| Q1 2014 | $62,000 | – | 25,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,200,000 | $1,265,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 1,982,137 | $1,140,000 | 0.05% |
| Cutter & CO Brokerage, Inc. | 94,500 | $54,000 | 0.03% |
| PRINCETON CAPITAL MANAGEMENT LLC | 25,000 | $14,000 | 0.02% |
| LUPO SECURITIES, LLC | 3,700 | $2,000 | 0.02% |
| B. Riley Wealth Advisors, Inc. | 28,000 | $17,000 | 0.00% |
| WADE G W & INC | 30,000 | $17,000 | 0.00% |
| Cannell & Co. | 90,000 | $52,000 | 0.00% |
| Focused Wealth Management, Inc | 2,955 | $2,000 | 0.00% |
| TRUST DEPARTMENT MB FINANCIAL BANK N A | 10,000 | $6,000 | 0.00% |